Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $7.03 Million - $8.74 Million
-9,100 Reduced 70.54%
3,800 $3.37 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $7.32 Million - $9.18 Million
-10,100 Reduced 43.91%
12,900 $11.7 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $14.7 Million - $19.6 Million
-24,800 Reduced 51.88%
23,000 $17.9 Million
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $15.8 Million - $18.6 Million
30,100 Added 170.06%
47,800 $27.9 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $6.35 Million - $8.75 Million
-14,600 Reduced 45.2%
17,700 $9.51 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $315,666 - $422,082
900 Added 2.87%
32,300 $15.1 Million
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $23.2 Million - $27.3 Million
-74,800 Reduced 70.43%
31,400 $10.8 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $29.9 Million - $34.8 Million
93,000 Added 704.55%
106,200 $38.9 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $15 Million - $17.1 Million
-50,600 Reduced 79.31%
13,200 $4.27 Million
Q2 2022

Aug 03, 2022

BUY
$278.73 - $327.27 $7.55 Million - $8.87 Million
27,100 Added 73.84%
63,800 $20.7 Million
Q1 2022

May 04, 2022

BUY
$234.69 - $291.66 $3.8 Million - $4.72 Million
16,200 Added 79.02%
36,700 $10.5 Million
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $3.37 Million - $4.19 Million
15,000 Added 272.73%
20,500 $5.66 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $4.32 Million - $5.32 Million
-19,500 Reduced 78.0%
5,500 $1.27 Million
Q2 2017

Aug 14, 2017

BUY
N/A
25,000
25,000 $2.06 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.